港股异动 | 博安生物(06955)盘中拉升15% 拟购回价值不超过2亿港元公司股份 BA5101于中国澳门获批上市

智通财经05-19

智通财经APP获悉，博安生物(06955)盘中拉升逾15%，截至发稿，涨7.64%，报6.77港元，成交额1.56亿港元。消息面上，近日，博安生物发布公告，根据本公司股东于本公司2025年6月5日举行的股东周年大会上批准的购回股份的一般授权及(如适用)未来股东于本公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时于公开市场上购回价值不超过2亿港元的本公司股份。另外，据博安生物官微消息，其...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2636862698?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-19 10:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2636862698","market":"us","top_or_hot":-1,"title":"港股异动 | 博安生物(06955)盘中拉升15% 拟购回价值不超过2亿港元公司股份 BA5101于中国澳门获批上市","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，博安生物(06955)盘中拉升逾15%，截至发稿，涨7.64%，报6.77港元，成交额1.56亿港元。消息面上，近日，博安生物发布公告，根据本公司股东于本公司2025年6月5日举行的股东周年大会上批准的购回股份的一般授权及(如适用)未来股东于本公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时于公开市场上购回价值不超过2亿港元的本公司股份。另外，据博安生物官微消息，其...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1443279.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 博安生物(06955)盘中拉升15% 拟购回价值不超过2亿港元公司股份 BA5101于中国澳门获批上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 博安生物(06955)盘中拉升15% 拟购回价值不超过2亿港元公司股份 BA5101于中国澳门获批上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-19 10:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1443279.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，博安生物(06955)盘中拉升逾15%，截至发稿，涨7.64%，报6.77港元，成交额1.56亿港元。消息面上，近日，博安生物发布公告，根据本公司股东于本公司2025年6月5日举行的股东周年大会上批准的购回股份的一般授权及(如适用)未来股东于本公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时于公开市场上购回价值不超过2亿港元的本公司股份。另外，据博安生物官微消息，其...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1443279.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1443279.html","article_id":"2636862698","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2636862698","pubTimestamp":1779158139,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，博安生物盘中拉升逾15%，截至发稿，涨7.64%，报6.77港元，成交额1.56亿港元。另外，据博安生物官微消息，其自主开发的度拉糖肽注射液正式获得中国澳门特别行政区政府药物监督管理局的上市批准，用于成人2型糖尿病患者的血糖控制。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4588":"碎股","VXUS":"国际股票ETF-Vanguard","BK4585":"ETF&股票定投概念","BK1161":"生物科技","06955":"博安生物","IPOS":"Renaissance International IPO ETF"},"translate_title":"Changes in Hong Kong stocks | Boan Biotech (06955) rose by 15% during the intraday session and plans to repurchase the company's shares with a value of no more than HK$200 million. BA5101 was approved for listing in Macau, China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06955":1.5,"VXUS":1.5,"IPOS":1.5},"content_text":"智通财经APP获悉，博安生物(06955)盘中拉升逾15%，截至发稿，涨7.64%，报6.77港元，成交额1.56亿港元。消息面上，近日，博安生物发布公告，根据本公司股东于本公司2025年6月5日举行的股东周年大会上批准的购回股份的一般授权及(如适用)未来股东于本公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时于公开市场上购回价值不超过2亿港元的本公司股份。另外，据博安生物官微消息，其自主开发的度拉糖肽注射液(BA5101)正式获得中国澳门特别行政区政府药物监督管理局的上市批准，用于成人2型糖尿病患者的血糖控制。该产品为全球首个且当前唯一获批上市的度易达®(Trulicity®)生物类似药，也是首个在中国澳门获批上市的国产度拉糖肽注射液。此外，BA5101也已在美国获准开展临床试验，为其后续在各大国际市场的开发奠定基础。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2636862698","isCrawlerRequest":true}